¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"serum response factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
platelet activating factor
Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
platelet factor 3
Ç÷¼ÒÆÇÀÎÀÚ3
platelet factor 4
Ç÷¼ÒÆÇÀÎÀÚ4
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
precipitation factor
ħÀüÀÎÀÚ
predisposing factor
¼±Çà¿äÀÎ
prognostic factor
¿¹ÈÄÀÎÀÚ
prolactin inhibitory factor
ÇÁ·Î¶ôƾºÐºñ¾ïÁ¦ÀÎÀÚ
prolactin releasing factor
ÇÁ·Î¶ôƾºÐºñÀÎÀÚ
properdin factor B
ÇÁ·ÎÆä¸£µòBÀÎÀÚ
properdin factor D
ÇÁ·ÎÆä¸£µòDÀÎÀÚ
properdin factor E
ÇÁ·ÎÆä¸£µòEÀÎÀÚ
protein synthesis factor
´Ü¹éÇÕ¼ºÀÎÀÚ
psychogenic factor
Á¤½Å¼ºÀÎÀÚ
psychological factor
½É¸®¿äÀÎ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
prolactin inhibitory factor
ÇÁ·Î¶ôƾºÐºñ¾ïÁ¦ÀÎÀÚ
prolactin releasing factor
ÇÁ·Î¶ôƾºÐºñÀ¯¹ßÀÎÀÚ
protein synthesis factor
´Ü¹éÇÕ¼ºÀÎÀÚ
psychogenic factor
Á¤½Å¼º¿ä¼Ò
psychological factor
½É¸®¿ä¼Ò
psychosocial factor
½É¸®»çȸÀû¿äÀÎ
quality factor
Áú¿ä¼Ò, Á¤¼ºÀÎÀÚ
racial factor
ÀÎÁ¾¿äÀÎ
radiation weighting factor
¹æ»ç¼±°¡Áß°è¼ö
realization factor
½ÇÇöÀÎÀÚ
recruitment factor
µ¿¿øÀÎÀÚ
reducing factor
ȯ¿øÀÎÀÚ
reinforcing factor
°È¿äÀÎ
relaxing factor
ÀÌ¿ÏÀÎÀÚ
resistance factor
³»¼ºÀÎÀÚ, °ßµõÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
plasma thromboplastic factor
Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ.
plasma thromboplastin factor
Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ.
platelet activating factor
Ç÷¼ÒÆÇ Ȱ¼º ÀÎÀÚ
platelet factor 4
Ç÷¼ÒÆÇÀÎÀÚ(úìá³÷ùì×í) 4
platelet factor 4=PF4
Ç÷¼ÒÆÇÀÎÀÚ 4
platelet factor III
Ç÷¼ÒÆÇÁ¦»ïÀÎÀÚ.
platelet-activating factor (PAF)
Ç÷¼ÒÆÇ Ȱ¼ºÈÀÎÀÚ
platelet-activating factor (paf)
Ç÷¼ÒÆÇȰ¼ºÈÀÎÀÚ(úìá³÷ùüÀàõûùì×í)
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡ Áõ½ÄÀÎÀÚ
platelet-derived growth factor(PDGF)
Ç÷¼ÒÆÇ À¯·¡ ¼ºÀå ÀÎÀÚ
platelet-derived growth factor(pdgf)
ÆÇ-À¯µµ¼ºÀåÀÎÀÚ(úìá³÷ù-ë¯Óôà÷íþì×í)
power factor
Ãâ·Â·ü(õóæ³ëÒ), ¿ª·ü(æ³ëÒ).
predisposing factor
¼ÒÀμº ¿äÀÎ, ¼±Çà¿äÀÎ.
prognostic factor
¿¹ÈÄÀÎÀÚ
prolactin inhibiting factor
ÇÁ·Ñ¶ôƾ(ºÐºñ)¾ïÁ¦ÀÎÀÚ.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
response decline
¹ÝÀÀÁ¡¸ê(ÚãëëïÂØþ).
response element
¹ÝÀÀ¿ä¼Ò
response frequency
¹ÝÀÀ Á֯ļö
response function
¹ÝÀÀÇÔ¼ö
response modulation
¹ÝÀÀÁ¶Á¤
response prevention
¹ÝÀÀ¹æÁö(ÚãëëÛÁò)
response rate
¹ÝÀÀÀ²
response set
¹ÝÀÀ¼¼Æ®
reticulocyte response
¸Á(»ó)ÀûÇ÷±¸¹ÝÀÀ(ØÑ ßÒîåúìϹÚãëë).
reticulocyte response
¸Á(»ó)ÀûÇ÷±¸¹ÝÀÀ(¡îåúìϹÚãëë)
secondary evoked response
ÀÌÂ÷À¯¹ß¹ÝÀÀ(ì£óë¯Û¡Úãëë).
secondary evoked response
ÀÌÂ÷À¯¹ß¹ÝÀÀ(ì£óë¯Û¡Úãëë)
secondary immune response
ÀÌÂ÷Àû ¸é¿ª¹ÝÀÀ(ì£óîÜØóæ¹Úãëë).
secondary immune response
ÀÌÂ÷Àû ¸é¿ª¹ÝÀÀ(ì£óîÜØóæ¹Úãëë).
sensitization response
°¨ÀÛ¹ÝÀÀ(¡Úãëë).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
14
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½